QA: Centessa Pharmaceuticals plc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001847903_2025_Centessa_Pharmaceuticals_plc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001847903, Centessa Pharmaceuticals plc

  xvar xval
0 AssetsCurrent 536,409,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 744,000
3 remainder_Assets 39,645,000
4 LiabilitiesCurrent 57,998,000
5 LiabilitiesNoncurrent 117,255,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 50,811,000
9 ResearchAndDevelopmentExpense 150,244,000
10 remainder_Expenses 12,934,000
11 remainder_Revenues 0
12 remainder_NetIncome -21,768,000
13 remainder_ComprehensiveNetIncome 2,720,000
  yvar yval
0 Assets 576,798,000
1 Liabilities 175,253,000
2 Expenses 213,989,000
3 Revenues 0
4 StockholdersEquity 401,545,000
5 NetIncome -235,757,000
6 ComprehensiveNetIncome -234,397,000
7 BaseVar 495,264,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.70
9 EconomicCapitalRatio 2.82

Edgar->Model Mapping

Feature Distribution

Change over Time